“Concomitant or sequential exposure to …- or minimally toxic concentrations of bortezomib or other proteasome inhibitors and either HA14-1 or gossypol resulted in a striking increase in Bax/Bak conformational change/translocation, cytochrome c release, caspase activation, and synergistic induction of apoptosis in both GC- and ABC-type cells.”